These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32385827)

  • 1. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
    Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
    Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of renal oncocytoma and renal clear cell carcinoma using relative CT enhancement ratio.
    Ren A; Cai F; Shang YN; Ma ES; Huang ZG; Wang W; Lu Y; Zhang XZ
    Chin Med J (Engl); 2015 Jan; 128(2):175-9. PubMed ID: 25591558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.
    Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A
    AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.
    Dhyani M; Grajo JR; Rodriguez D; Chen Z; Feldman A; Tambouret R; Gervais DA; Arellano RS; Hahn PF; Samir AE
    Abdom Radiol (NY); 2017 Jun; 42(6):1734-1743. PubMed ID: 28197683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the Aortic-Lesion-Attenuation-Difference (ALAD) and Peak Early-Phase Enhancement Ratio (PEER) to differentiate benign from malignant renal masses.
    Kahn AE; Lomax SJ; Bajalia EM; Ball CT; Thiel DD
    Can J Urol; 2020 Aug; 27(4):10278-10284. PubMed ID: 32861252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
    Pierorazio PM; Hyams ES; Tsai S; Feng Z; Trock BJ; Mullins JK; Johnson PT; Fishman EK; Allaf ME
    Urology; 2013 Jun; 81(6):1265-71. PubMed ID: 23601445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.
    Grajo JR; Terry RS; Ruoss J; Noennig BJ; Pavlinec JG; Bozorgmehri S; Crispen PL; Su LM
    Urology; 2019 Mar; 125():123-130. PubMed ID: 30552939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
    Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
    AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of multidetector computed tomography to differentiate between renal cell carcinoma and oncocytoma. A model validation.
    Paño B; Soler A; Goldman DA; Salvador R; Buñesch L; Sebastià C; Nicolau C
    Br J Radiol; 2020 Nov; 93(1115):20200064. PubMed ID: 32706993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of renal cell carcinoma, oncocytoma, and lipid-poor angiomyolipoma by unenhanced, nephrographic, and delayed phase contrast-enhanced computed tomography.
    Ishigami K; Pakalniskis MG; Leite LV; Lee DK; Holanda DG; Rajput M
    Clin Imaging; 2015; 39(1):76-84. PubMed ID: 25457535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma.
    Kim JI; Cho JY; Moon KC; Lee HJ; Kim SH
    Radiology; 2009 Aug; 252(2):441-8. PubMed ID: 19508984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four-phase computed tomography helps differentiation of renal oncocytoma with central hypodense areas from clear cell renal cell carcinoma.
    Qu JY; Jiang H; Song XH; Wu JK; Ma H
    Diagn Interv Radiol; 2023 Mar; 29(2):205-211. PubMed ID: 36960636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of Renal Tumor Histotypes: Usefulness of Quantitative Analysis of Contrast-Enhanced Ultrasound.
    Lu Q; Huang BJ; Xue LY; Fan PL; Wang WP
    AJR Am J Roentgenol; 2015 Sep; 205(3):W335-42. PubMed ID: 26295670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 papillary renal cell carcinoma: differentiation from Type 2 papillary RCC on multiphasic MDCT.
    Young JR; Coy H; Douek M; Lo P; Sayre J; Pantuck AJ; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1911-1918. PubMed ID: 28265706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histogram analysis of small solid renal masses: differentiating minimal fat angiomyolipoma from renal cell carcinoma.
    Chaudhry HS; Davenport MS; Nieman CM; Ho LM; Neville AM
    AJR Am J Roentgenol; 2012 Feb; 198(2):377-83. PubMed ID: 22268181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT.
    Young JR; Young JA; Margolis DJA; Sauk S; Sayre J; Pantuck AJ; Raman SS
    Acad Radiol; 2017 Oct; 24(10):1226-1232. PubMed ID: 28528853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.
    Lee-Felker SA; Felker ER; Tan N; Margolis DJ; Young JR; Sayre J; Raman SS
    AJR Am J Roentgenol; 2014 Nov; 203(5):W516-24. PubMed ID: 25341166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.